Immune Response of Host的临床试验
总计6720个结果
-
National Eye Institute (NEI)The Emmes Company, LLC终止
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.完全的
-
Alexion Pharmaceuticals终止
-
Brigham and Women's HospitalMassachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center 和其他合作者完全的
-
Astellas Pharma Inc完全的
-
Nanfang Hospital, Southern Medical UniversityShanghai iCELL Biotechnology Co., Ltd, Shanghai, China尚未招聘急性移植物抗宿主病
-
Pharmacyclics LLC.Janssen Research & Development, LLC完全的慢性移植物抗宿主病美国, 澳大利亚, 奥地利, 加拿大, 中国, 克罗地亚, 法国, 德国, 匈牙利, 意大利, 日本, 大韩民国, 新加坡, 西班牙, 台湾
-
Gruppo Italiano Trapianto di Midollo Osseo完全的
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)终止
-
St. Petersburg State Pavlov Medical UniversityMinistry of Health, Russian Federation完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Stanford University完全的
-
H. Lee Moffitt Cancer Center and Research Institute完全的
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的
-
Cancer Institute and Hospital, Chinese Academy...307 Hospital of PLA; Chinese PLA General Hospital; Zhejiang University; Peking Union Medical College未知
-
M.D. Anderson Cancer CenterAmgen终止
-
University of Erlangen-Nürnberg Medical School终止沮丧 | 生活质量 | 白血病 | 移植物抗宿主病 | 干细胞移植并发症 | 血液肿瘤德国
-
UMC Utrecht终止
-
Hannah Choe, MDNational Cancer Institute (NCI); Plexxikon终止
-
Astellas Pharma Inc完全的骨髓移植 | 移植物抗宿主病 | 移植物抗宿主病 | 移植物抗宿主病日本
-
Baylor Research InstituteMillennium Pharmaceuticals, Inc.未知